accueil Publications ayant en commun
la "réaction de Maillard" et le "diabète"
Madéglucyl médicament "issu de la réaction de Maillard ?" dans le traitement du diabète
O'Brien, J, Nursten, H.E., Crabbe, M.J.C. and Ames, J.E. (eds.) The Maillard Reaction in Foods and Medicine (1998) pp.464. Royal Society of Chemistry Press, Cambridge. ISBN 0 85404 733 6.
Benhamou Pierre-Yves, Professeur Université Grenoble, Diabète, glycation, marqueurs et réaction de Maillard
Bellmeunt MJ, Portero M, Pamplona R, Cosso L, Odetti P, Prat J,, Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age, Biochim. Biophys. Acta, 1995, 1272: 53-60
Oimoni M, Igaki N. Aminoguanidina inhibits 3-deoxyglucosone during the advanced Maillard reaction. Diabet Res Clin Pract 1989;6:311-3.
Henle T, Deppisch R, Ritz E. The Maillard reaction - from food chemistry to uraemic research (editorial). Nephrol Dial Transplant 1996; 11: 1718-22
Monnier V. The Maillard reaction in aging, diabetes and nutrition. In: Baynes JW, Monnier V, editors. NIH conference. New York: A.R. Liss, 1988; 1-22.
Sell DR , Monnier VM .End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990 ; 85 : 380-4.
Brownlee M , Cerami A , Vlassara H : Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N.Engl.J.Med. 1988 ; 318 : 1315-21.
Shaw, S.M. and Crabbe, M.J.C. Non-specific binding of lysine-glucose-derived Maillard products to macrophages outweighs specific receptor-mediated interactions. Food Chemistry (1995) 52, 399-404.
Crabbe, M.J.C. The Maillard Reaction. Trends in Food Science and Technology (1997) 8, 211-212..
Crabbe, M.J.C. (1998) Cataract as a conformational disease - the Maillard reaction, alpha crystallin and chemotherapy. Cellular and Molecular Biology 44, 1047-1051.
Crabbe, M.J.C., Üstündag, B., Cay, M., Naziroglu, M., Ilhan, N., Õzercan, I.H., and Dilsiz, N. Effects of vitamin E on serum glucose levels and nephropathy in streptozotocin-diabetic rats. The Maillard Reaction in Foods and Medicine (Eds. J. O'Brien, H.E.Nursten, M.J.C.Crabbe and J.M.Ames) (1998) Royal Society of Chemistry Press, Cambridge. ISBN 0 85404 733 6 p. 268-272.
Üstündag, B., Cay, M., Naziroglu, M., Ilhan, N., Dilsiz, N. and Crabbe, M.J.C. A study of renin-angiotensin-aldosterone in streptozotocin-diabetic rats. Proceedings of the Sixth International Symposium on the Maillard Reaction. (1997) p. 121. In : O'Brien, J, Nursten, H.E., Crabbe, M.J.C. and Ames, J.E. (eds.) The Maillard Reaction in Foods and Medicine (1998) p. 450. Royal Society of Chemistry Press, Cambridge. ISBN 0 85404 733 6.
Njoroge FG, Monnier VM. The chemistry of the Maillard reaction under physiological conditions: a review. Prog Clin Biol Res 1989; 304: 85-91
Monnier V. Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM, ed. Proceedings of the NIH Conference on the Maillard Reaction in Aging, Diabetes and Nutrition. New York: Liss, 1989: 1-22.
Niwa T, Takeda N, Miyazaki T, Yoshizumi H, Tatematsu A, Maeda K, et al. Elevated serum levels of 3-deoxyglu-cosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients. Nephron 1995; 669: 438-43.
Takahashi M, Ohishi T, Aoshima H, Kawana K, Kushida K, Inoue T, et al. The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia 1993; 36: 664-7.